We hardly ever stop to take a breath! Keep up-to-date with the Lung Health Foundation’s latest news:
After months of consistent patient advocacy, the Patented Medicines Prices Review Board (PMPRB) has announced that they will delay the implementation of their pricing guidelines until January 2021.
The Lung Health Foundation supports efforts to provide safer work environments for the millions of Canadians living with lung disease during the COVID-19 pandemic. Learn more about our position on protecting patients.
Recognizing the significant and growing human and economic burden that lung disease represents, we continuously examine our business model, looking for ways of more effectively and efficiently delivering on our mission and investing the funds
Missed our COVID-19 vaccine Q&A on Instagram Live? Here’s the replay!
Want to learn more about the most common variants in Canada, and what level of protection each vaccine offers against them? View our latest infographic.
We want to help you make the best choice for your family. Submit your questions ahead of time and join us on July 27th at 7:00pm ET.
Why the Burden of Pneumococcal Disease is Underestimated and Misunderstood: Implications for Public Health Planning
In 2017-18, pneumonia led to 138,485 emergency department visits across Canada. It was the ninth leading cause of a trip to the ER.
Lung Health Foundation Alerts
The Lung Health Foundation is monitoring the availability of several inhaled respiratory medications after receiving reports of brief local shortages. As of March 31, there are no largescale shortages reported, though individual pharmacies may temporarily